W J Hogan1, A J Moon-Grady1, Y Zhao1, N M Cresalia1, H Nawaytou1, E Quezada1, M Brook1, P McQuillen2, S Peyvandi1. 1. Division of Pediatric Cardiology, Department of Pediatrics, The University of California San Francisco, San Francisco, CA, USA. 2. Division of Critical Care, Department of Pediatrics, The University of California San Francisco, San Francisco, CA, USA.
Abstract
OBJECTIVE: Fetal cerebrovascular resistance is influenced by several factors in the setting of intact autoregulation to allow for normal cerebral blood flow and oxygenation. Maternal hyperoxygenation (MH) allows for acute alterations in fetal physiology and can be a tool to test cerebrovascular reactivity in late-gestation fetuses. In this study, we utilized MH to evaluate cerebrovascular reactivity in fetuses with specific congenital heart disease (CHD). METHODS: This was a cross-sectional study of fetuses with complex CHD compared to controls without CHD. CHD cases were grouped according to physiology into: left-sided obstructive lesion (LSOL), right-sided obstructive lesion (RSOL) or dextro-transposition of the great arteries (d-TGA). Subjects underwent MH testing during the third-trimester fetal echocardiogram. The pulsatility index (PI) was calculated for the fetal middle cerebral artery (MCA), umbilical artery (UA) and branch pulmonary artery (PA). The change in PI from baseline to during MH was compared between each CHD group and controls. RESULTS: Sixty pregnant women were enrolled (CHD, n = 43; control, n = 17). In the CHD group, there were 27 fetuses with LSOL, seven with RSOL and nine with d-TGA. Mean gestational age was 33.9 (95% CI, 33.6-34.2) weeks. At baseline, MCA-PI Z-score was lowest in the LSOL group (-1.8 (95% CI, -2.4 to -1.2)) compared with the control group (-0.8 (95% CI, -1.3 to -0.3)) (P = 0.01). In response to MH, MCA-PI Z-score increased significantly in the control and d-TGA groups but did not change significantly in the LSOL and RSOL groups. The change in MCA-PI Z-score was significantly higher in the control group than in the LSOL group (0.9 (95% CI, 0.42-1.4) vs 0.12 (95% CI, -0.21 to 0.45); P = 0.03). This difference was more pronounced in the LSOL subgroup with retrograde aortic arch flow. Branch PA-PI decreased significantly in response to MH in all groups, with no difference in the change from baseline to MH between the groups, while UA-PI was unchanged during MH compared with at baseline. CONCLUSIONS: The fetal cerebrovascular response to MH varies based on the underlying CHD diagnosis, suggesting that cardiovascular physiology may influence the autoregulatory capacity of the fetal brain. Further studies are needed to determine the clinical implications of these findings on long-term neurodevelopment in these at-risk children.
OBJECTIVE: Fetal cerebrovascular resistance is influenced by several factors in the setting of intact autoregulation to allow for normal cerebral blood flow and oxygenation. Maternal hyperoxygenation (MH) allows for acute alterations in fetal physiology and can be a tool to test cerebrovascular reactivity in late-gestation fetuses. In this study, we utilized MH to evaluate cerebrovascular reactivity in fetuses with specific congenital heart disease (CHD). METHODS: This was a cross-sectional study of fetuses with complex CHD compared to controls without CHD. CHD cases were grouped according to physiology into: left-sided obstructive lesion (LSOL), right-sided obstructive lesion (RSOL) or dextro-transposition of the great arteries (d-TGA). Subjects underwent MH testing during the third-trimester fetal echocardiogram. The pulsatility index (PI) was calculated for the fetal middle cerebral artery (MCA), umbilical artery (UA) and branch pulmonary artery (PA). The change in PI from baseline to during MH was compared between each CHD group and controls. RESULTS: Sixty pregnant women were enrolled (CHD, n = 43; control, n = 17). In the CHD group, there were 27 fetuses with LSOL, seven with RSOL and nine with d-TGA. Mean gestational age was 33.9 (95% CI, 33.6-34.2) weeks. At baseline, MCA-PI Z-score was lowest in the LSOL group (-1.8 (95% CI, -2.4 to -1.2)) compared with the control group (-0.8 (95% CI, -1.3 to -0.3)) (P = 0.01). In response to MH, MCA-PI Z-score increased significantly in the control and d-TGA groups but did not change significantly in the LSOL and RSOL groups. The change in MCA-PI Z-score was significantly higher in the control group than in the LSOL group (0.9 (95% CI, 0.42-1.4) vs 0.12 (95% CI, -0.21 to 0.45); P = 0.03). This difference was more pronounced in the LSOL subgroup with retrograde aortic arch flow. Branch PA-PI decreased significantly in response to MH in all groups, with no difference in the change from baseline to MH between the groups, while UA-PI was unchanged during MH compared with at baseline. CONCLUSIONS: The fetal cerebrovascular response to MH varies based on the underlying CHD diagnosis, suggesting that cardiovascular physiology may influence the autoregulatory capacity of the fetal brain. Further studies are needed to determine the clinical implications of these findings on long-term neurodevelopment in these at-risk children.
Authors: M T Donofrio; Y A Bremer; R M Schieken; C Gennings; L D Morton; B W Eidem; F Cetta; C B Falkensammer; J C Huhta; C S Kleinman Journal: Pediatr Cardiol Date: 2003 Sep-Oct Impact factor: 1.655
Authors: Mary T Donofrio; Anita J Moon-Grady; Lisa K Hornberger; Joshua A Copel; Mark S Sklansky; Alfred Abuhamad; Bettina F Cuneo; James C Huhta; Richard A Jonas; Anita Krishnan; Stephanie Lacey; Wesley Lee; Erik C Michelfelder; Gwen R Rempel; Norman H Silverman; Thomas L Spray; Janette F Strasburger; Wayne Tworetzky; Jack Rychik Journal: Circulation Date: 2014-04-24 Impact factor: 29.690
Authors: Catherine Limperopoulos; Wayne Tworetzky; Doff B McElhinney; Jane W Newburger; David W Brown; Richard L Robertson; Nicolas Guizard; Ellen McGrath; Judith Geva; David Annese; Carolyn Dunbar-Masterson; Bethany Trainor; Peter C Laussen; Adré J du Plessis Journal: Circulation Date: 2009-12-21 Impact factor: 29.690
Authors: M J Simchen; J Tesler; T Azami; D Preiss; L Fedorko; E Goldszmidz; J Fisher; J Kingdom; C Slorach; L K Hornberger Journal: Ultrasound Obstet Gynecol Date: 2005-10 Impact factor: 7.299
Authors: O M Turan; S Turan; S Gungor; C Berg; D Moyano; U Gembruch; K H Nicolaides; C R Harman; A A Baschat Journal: Ultrasound Obstet Gynecol Date: 2008-08 Impact factor: 7.299
Authors: David Attwell; Alastair M Buchan; Serge Charpak; Martin Lauritzen; Brian A Macvicar; Eric A Newman Journal: Nature Date: 2010-11-11 Impact factor: 49.962
Authors: Shabnam Peyvandi; Duan Xu; Yan Wang; Whitnee Hogan; Anita Moon-Grady; A James Barkovich; Orit Glenn; Patrick McQuillen; Jing Liu Journal: J Am Heart Assoc Date: 2020-12-21 Impact factor: 5.501
Authors: Sara Ottolenghi; Giuseppina Milano; Michele Dei Cas; Tina O Findley; Rita Paroni; Antonio F Corno Journal: Front Pharmacol Date: 2021-11-29 Impact factor: 5.810
Authors: Lan Zhang; Hongli Liu; Shuai Huang; Chao Tong; Zhigang Wang; Hongbo Qi; Philip N Baker; Mark D Kilby Journal: Front Med (Lausanne) Date: 2022-04-14